Expression of different isoforms of utrophin in human muscle; potentials for therapy of Duchenne muscular dystrophy

Expression of different isoforms of utrophin in human muscle; potentials for therapy of Duchenne muscular dystrophy

Bibliographic Details
Main Authors:	Sewry, C, Nowak, K, Ehmsen, J, Davies, K
Format:	Conference item
Published:	2004

Similar Items

Utrophin in the therapy of Duchenne Muscular Dystrophy
by: Potter, A, et al.
Published: (2006)

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
by: Perkins, K, et al.
Published: (2002)

Utrophin upregulation in Duchenne muscular dystrophy.
by: Hirst, R, et al.
Published: (2005)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019)

Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in Duchenne and Becker muscular dystrophy muscle biopsies
by: Janghra, N, et al.
Published: (2016)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
by: Griffin, J, et al.
Published: (2002)

Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
by: Fairclough, R, et al.
Published: (2012)

Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy
by: Fairclough, R, et al.
Published: (2008)

Utrophin in therapy of Duchenne muscular distrophy
by: Fisher, R
Published: (2001)

A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
by: Sewry, C, et al.
Published: (2005)

New orally available compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD)
by: Fairclough, R, et al.
Published: (2014)

Progress in therapy for Duchenne muscular dystrophy.
by: Fairclough, R, et al.
Published: (2011)

Progress in therapy for Duchenne muscular dystrophy
by: Fairclough, R, et al.
Published: (2011)

Utrophin upregulation and microRNAs - two avenues of Duchenne muscular dystrophy therapy research
by: Bareja, A
Published: (2011)

Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers.
by: Matthews, P, et al.
Published: (1995)

Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
by: Chancellor, DR, et al.
Published: (2011)

Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.
by: Nowak, K, et al.
Published: (2004)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
by: Perkins, K, et al.
Published: (2018)

Analysis of the transcriptional control of utrophin promoters as a therapeutic strategy for Duchenne muscular dystrophy (DMD).
by: Perkins, K, et al.
Published: (2000)

From diagnosis to therapy in Duchenne muscular dystrophy
by: Babbs, A, et al.
Published: (2020)

Mechanism of action studies of the utrophin modulator ezutromid for the treatment of Duchenne muscular dystrophy
by: Wilkinson, I
Published: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019)

Duchenne muscular dystrophy - past, present and future
by: Davies, K
Published: (2002)

Pharmacological advances for treatment in Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2017)

Therapeutic approaches for Duchenne muscular dystrophy
by: Roberts, TC, et al.
Published: (2023)

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.
by: Fairclough, R, et al.
Published: (2013)

Micro-dystrophin genes bring hope of an effective therapy for duchenne muscular dystrophy
by: Davies, K, et al.
Published: (2019)

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy.
by: Goyenvalle, A, et al.
Published: (2011)

Imaging biomarkers for Duchenne muscular dystrophy
by: Koppaka, Sisir
Published: (2017)

Molecular genetics of Duchenne muscular dystrophy.
by: Kunkel, L, et al.
Published: (1986)

The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.
by: Perkins, K, et al.
Published: (2001)

Hunting for a cure: the therapeutic potential of gene therapy in Duchenne muscular dystrophy
by: Hashim, Hasnur Zaman, et al.
Published: (2014)

Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2015)

DUCHENNE MUSCULAR DYSTROPHY FROM GENE DIAGNOSIS TO MOLECULAR THERAPY
by: , Masafumi Matsuo
Published: (2003)

Duchenne muscular dystrophy from gene diagnosis to molecular therapy
by: , Masafumi Matsuo
Published: (2003)

Future clinical and biomarker development for SMTC1100, the first utrophin modulator to enter clinical trials for Duchenne Muscular Dystrophy (DMD)
by: Tinsley, J, et al.
Published: (2013)

Biomarker potential of extracellular miRNAs in Duchenne Muscular Dystrophy
by: Coenen-Stass, A, et al.
Published: (2017)

Cloning of the Duchenne/Becker muscular dystrophy locus.
by: Monaco, A, et al.
Published: (1988)

Molecular studies of progressive muscular dystrophy (Duchenne).
by: Kunkel, L, et al.
Published: (1987)

Engineering exon-skipping vectors expressing U7 snRNA constructs for Duchenne muscular dystrophy gene therapy.
by: Goyenvalle, A, et al.
Published: (2011)